Aptar Pharma’s French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as contract test labs for extractables testing with the FDA. Aptar Pharma can now provide pharma and biopharma companies working with its drug delivery devices with extractables testing for batch release of their drug products.

This is the second successful FDA inspection at Aptar’s sites at Le Vaudreuil and Val-de-Reuil, with no 483 inspectional observations made. The Aptar Pharma sites are ISO-15378 certified and operate under a cGMP-compliant quality system.